Developing Highly Signaling-Pathway Selective Molecules Using Mebias’ 19Fluid Platform

Time: 9:30 am
day: Day One

Details:

• 19F NMR of native GPCRs in solution
• Conformation driven drug discovery to determine pathway selectivity
• Integrating pathway selectivity into drug discovery